Helius Medical Technologies (HSDT) Reports Q1 Revenue of $190K
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
May 12, 2022 6:50 AM EDT-- Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing --
NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended March 31, 2022.
First Quarter and Recent Business Updates
U.S. commercial launch of PoNS® for multiple sclerosis (MS) commenced with 23 prescriptions written and 2 filled.Finalizing activities for participation of... More